Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Influenza Information Center

Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins

Brian Park, PharmD

September 19, 2022

The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.

Ob/Gyn Information Center

FDA Panel Meeting Scheduled to Discuss Rx-to-OTC Switch of Oral Contraceptive Opill

Brian Park, PharmD

September 16, 2022

Opill contains 0.075 mg of norgestrel, a single active steroid ingredient.

Maternal Tdap vaccination lowers risk of pertussis in newborns

Ob/Gyn Information Center

Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status

Brian Park, PharmD

September 12, 2022

GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.

Influenza Information Center

ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season

Brian Park, PharmD

September 2, 2022

In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.

Infectious Diseases Information Center

FDA Authorizes Omicron-Adapted Booster Doses of Moderna, Pfizer-BioNTech COVID-19 Vaccines

Brian Park, PharmD

September 1, 2022

The FDA has authorized the bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines as a single booster dose at least 2 months following the primary or booster vaccination.

Cardiovascular Disease Information Center

USPSTF Issues Final Recommendations on Statin Use for Primary Prevention of CVD

Brian Park, PharmD

August 29, 2022

These recommendations apply only to individuals without a history of CVD and who are not already taking statins.

Infectious Diseases Information Center, News

FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents

Brian Park, PharmD

August 22, 2022

The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.

Geriatrics Information Center, News

FDA Issues Final Rule for Over-the-Counter Hearing Aids

Brian Park, PharmD

August 17, 2022

The final rule takes effect in 60 days and consumers will be able to purchase hearing aids directly from stores or online retailers as soon as mid-October.